Initial Statement of Beneficial Ownership (3)
January 13 2022 - 04:52PM
Edgar (US Regulatory)
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP
OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
| 1. Name
and Address of Reporting Person * Hait William |
2. Date of Event Requiring Statement
(MM/DD/YYYY)
1/3/2022
|
3. Issuer Name and Ticker or Trading
Symbol JOHNSON & JOHNSON [JNJ] |
|
(Last)
(First)
(Middle)
ONE JOHNSON & JOHNSON PLAZA |
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)_____
Director _____
10% Owner
___X___ Officer (give title
below) _____
Other (specify below)
See Remarks / |
|
(Street)
NEW
BRUNSWICK, NJ 08933
(City)
(State)
(Zip)
|
5. If Amendment, Date Original
Filed(MM/DD/YYYY)
|
6. Individual or Joint/Group
Filing(Check Applicable
Line)_X_ Form filed by One Reporting
Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially
Owned
|
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
|
Common Stock |
223158.0000 |
D |
|
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying
Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative
Security |
5. Ownership Form of Derivative Security: Direct (D)
or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
|
Employee Stock Options (Right to Buy) (1) |
2/11/2017 |
2/9/2024 |
Common Stock |
59397.0000 |
$90.4400 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/10/2018 |
2/9/2025 |
Common Stock |
51484.0000 |
$100.0600 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/9/2019 |
2/8/2026 |
Common Stock |
54923.0000 |
$101.8700 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/13/2020 |
2/13/2027 |
Common Stock |
41097.0000 |
$115.6700 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/12/2021 |
2/11/2028 |
Common Stock |
37289.0000 |
$129.5100 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/11/2022 |
2/11/2029 |
Common Stock |
37911.0000 |
$131.9400 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/10/2023 |
2/10/2030 |
Common Stock |
49315.0000 |
$151.4100 |
D |
|
|
Employee Stock Options (Right to Buy) (1) |
2/8/2024 |
2/8/2031 |
Common Stock |
33593.0000 |
$164.6200 |
D |
|
|
Restricted Share Units (2) |
2/8/2024 |
(2) |
Common Stock |
3059.0000 |
(2) |
D |
|
|
Restricted Share Units (2) |
2/10/2023 |
(2) |
Common Stock |
3856.0000 |
(2) |
D |
|
|
Restricted Share Units (2) |
2/11/2022 |
(2) |
Common Stock |
7790.0000 |
(2) |
D |
|
| Explanation of
Responses: |
| (1) |
Vested and exercisable on
the third anniversary of the date of the grant. |
| (2) |
Each Restricted Share Unit
represents a contingent right to receive one share of Company
Common Stock and vests on the third anniversary of the date of
grant. |
Remarks:
haitpoa1.txt
Title: Executive Vice President, Chief External Innovation, Medical
Safety and Global Public Health Officer |
Reporting
Owners
|
|
Reporting Owner Name / Address |
Relationships
|
|
Director |
10% Owner |
Officer |
Other |
Hait William
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933 |
|
|
See Remarks |
|
Signatures
|
|
Raavi Deol, as attorney-in-fact for William
Hait |
|
1/13/2022 |
| **Signature of Reporting
Person |
Date |
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2022 to May 2022
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2021 to May 2022
